Haemonetics Corp (NYSE:HAE)

75.20
Delayed Data
As of Aug 12
 +2.13 / +2.92%
Today’s Change
43.50
Today|||52-Week Range
77.08
+41.78%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 86.50, with a high estimate of 90.00 and a low estimate of 74.00. The median estimate represents a +15.03% increase from the last price of 75.20.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Haemonetics Corp. This rating has held steady since June, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.68
Sales
$270.5M
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.52%
 
 
 
 
 
 
Growthannually 8.62%
 
 
 
 
 
 

Sales

Growthquarterly 3.44%
 
 
 
 
 
 
Growthannually 10.23%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.